- Home
- LLYVA vs BRKR Comparison
LLYVA vs BRKR Comparison
Compare LLYVA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLYVA
- BRKR
- Stock Information
- Founded
- LLYVA 1991
- BRKR 1960
- Country
- LLYVA United States
- BRKR United States
- Employees
- LLYVA N/A
- BRKR N/A
- Industry
- LLYVA Broadcasting
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- LLYVA Industrials
- BRKR Industrials
- Exchange
- LLYVA Nasdaq
- BRKR Nasdaq
- Market Cap
- LLYVA 7.1B
- BRKR 5.7B
- IPO Year
- LLYVA N/A
- BRKR 2000
- Fundamental
- Price
- LLYVA $71.86
- BRKR $36.70
- Analyst Decision
- LLYVA
- BRKR Buy
- Analyst Count
- LLYVA 0
- BRKR 12
- Target Price
- LLYVA N/A
- BRKR $57.50
- AVG Volume (30 Days)
- LLYVA 114.6K
- BRKR 2.6M
- Earning Date
- LLYVA 01-01-0001
- BRKR 05-07-2025
- Dividend Yield
- LLYVA N/A
- BRKR 0.55%
- EPS Growth
- LLYVA N/A
- BRKR N/A
- EPS
- LLYVA 0.27
- BRKR 0.52
- Revenue
- LLYVA N/A
- BRKR $3,446,100,000.00
- Revenue This Year
- LLYVA $7.29
- BRKR $6.37
- Revenue Next Year
- LLYVA N/A
- BRKR $4.64
- P/E Ratio
- LLYVA $266.55
- BRKR $69.91
- Revenue Growth
- LLYVA N/A
- BRKR 14.84
- 52 Week Low
- LLYVA $32.55
- BRKR $34.10
- 52 Week High
- LLYVA $79.63
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- LLYVA 44.58
- BRKR 43.87
- Support Level
- LLYVA $70.66
- BRKR $34.98
- Resistance Level
- LLYVA $77.08
- BRKR $37.97
- Average True Range (ATR)
- LLYVA 1.71
- BRKR 1.41
- MACD
- LLYVA -0.76
- BRKR 0.01
- Stochastic Oscillator
- LLYVA 15.44
- BRKR 22.75
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.